MedicaidPrior AuthMedium impact
BT202664: Pharmacy updates approved by Drug Utilization Review Board April 2026
Indiana Medicaid (IHCP)·IN · Neurology, Psychiatry, Endocrinology +4 more·Prior Authorization
Effective date
Jul 1, 2026
We identified it
Jun 18, 2026
Summary
Indiana Medicaid has updated prior authorization requirements and drug formulary preferences for multiple medication classes including antiseizure agents, growth hormones, mental health medications, and opioids. Many drugs are being removed from preferred lists or having new step therapy requirements added.
Action Required
By July 1, 2026: Review patient medication lists for affected drug classes (antiseizure, mental health, growth hormones, hemophilia, opioids). Update prior authorization workflows for newly restricted medications. Train staff on new step therapy requirements for drugs like Subvenite oral suspension (age restrictions) and Procentra (documentation requirements). Monitor formulary changes that may require medication switches for Indiana Medicaid patients.